This live online session will provide an excellent opportunity to;
- Overview of
- Current guidelines on management
- Recommendations for management in primary care including investigations and first line treatments
- Be updated on the availability of diagnostic, medical care
- Improve care and guidance for your patients
About our speaker;
Dr Gerald Coakley graduated from the Royal London Hospital Medical School in 1989. After training in Nottinghamshire and London, he was awarded an Arthritis Research Campaign Fellowship, allowing him to carry out research in immunology and immunogenetics relating to Rheumatoid Arthritis and Felty's syndrome at Guy's Hospital, part of King's College School of Medicine.
This led to his PhD in 2000. Felty’s syndrome is a rare complication of rheumatoid arthritis in which the spleen becomes enlarged and the neutrophil count (one of the white cell subtypes) falls, leaving the patient vulnerable to overwhelming infection.
He has worked as a Consultant Rheumatologist at Queen Elizabeth Hospital, Woolwich since 2000, and continued to work there after it merged with the other two sites that made up South London Healthcare Trust in 2009, and then with University Hospital Lewisham, with which it merged in 2013 to form Lewisham & Greenwich NHS Trust.
He was Director of Medical Education from 2003 to 2013, and from 2013 to 2018 was Clinical Director for Dermatology, Neurology and Rheumatology at Lewisham & Greenwich.
He has continued to develop his interests in rheumatoid and other forms of inflammatory arthritis, but is also interested in the full range of musculoskeletal pain disorders, including fibromyalgia.
Since 2001, he has been involved in the care of people with Chronic Fatigue Syndrome / Myalgic Encephalomyelitis (CFS/ME), and now runs a weekly private Fatigue Clinic at Keats House, St Thomas Street, London SE1.
In addition to these interests, he also has an interest in the evidence based management of septic arthritis, in which capacity he has chaired a national guideline group and published numerous papers, including in the BMJ, The Lancet and Lancet Infectious Diseases.
